LifeCodexx Successfully Completes Clinical Validation of its Noninvasive Prenatal Test Method of Trisomy 21

03-May-2012 - LifeCodexx AG announced the successful completion of the clinical validation study of its noninvasive test method for the detection of fetal trisomy 21 from maternal blood using Next Generation sequencing. First results from the prospective blinded multi-center study demonstrate highest clinical ...

Sequenom Announces European Licensing Agreement With LifeCodexx

16-Aug-2011 - Sequenom, Inc. announced it has partnered with LifeCodexx AG for the commercialization of prenatal laboratory testing services in Europe. The companies have agreed to collaborate in the development and launch of a trisomy 21 laboratory developed test and other aneuploidies testing in Germany, ...

GATC Biotech and LifeCodexx Develop a Diagnostic Test for Early Detection of Preeclampsia

Project is funded with 500,000 Euros from the BMBF

16-May-2011 - On the basis of next generation sequencing technologies GATC Biotech and LifeCodexx will develop a human genetic diagnostic test that will allow the detection of cell-free fetal DNA as an important early marker for Preeclampsia. The test would allow a reliable risk assessment before symptoms ...

Successful Pilot Study for Non-Invasive Prenatal Diagnostic Test to Determine Trisomy 21

19-Apr-2011 - At the moment, the only reliable way of diagnosing chromosomal irregularities during pregnancy is to use invasive prenatal methods. This causes miscarriage in about one per cent of these risky surgical procedures.Scientists from the Center for Prenatal Diagnosis and Human Genetics, Kudamm-199, in ...

GATC Subsidiary LifeCodexx Appoints Head of Commercial Operations

Former Brahms sales manager boosts LifeCodexx team

03-Nov-2010 - LifeCodexx AG announced that Dr. Martin Burow, a proven expert in the field of prenatal diagnostics, has joined its team as Head of Commercial Operations. Until the middle of 2010 Dr. Burow was Sales Manager Asia – Pacific at Brahms AG, which was taken over by ThermoFisher Scientific in 2009. He ...

GATC Subsidiary Lifecodexx AG Develops Tests for Prenatal Diagnostics

Former General Manager of Cogenics appointed as CEO

30-Apr-2010 - LifeCodexx AG has started operational research and development work on clinically validated diagnostic tests by using Next Generation Sequencing technologies. The work currently focuses on the field of prenatal diagnostics. LifeCodexx will utilize GATC Biotech’s 20 years of experience as well as ...